What is OrbitalRX?
OrbitalRX operates at the intersection of healthcare technology and supply chain logistics, providing pharmacy leaders with a robust platform to navigate the complexities of drug shortages. By dismantling traditional data silos, the company offers a centralized interface that aggregates critical pharmacy metrics. This technological infrastructure is essential for modern healthcare providers, as it enables proactive inventory management and mitigates the operational risks associated with medication scarcity. As a key player in the health-tech sector, OrbitalRX is effectively transforming how institutions manage pharmaceutical procurement and distribution, ensuring that patient care remains uninterrupted by supply volatility.
How much funding has OrbitalRX raised?
OrbitalRX has raised a total of $1.2M across 1 funding round:
Stock/Share Issuance
$1.2M
Stock/Share Issuance (2025): $1.2M, investors not publicly disclosed
Key Investors in OrbitalRX
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for OrbitalRX?
With this major strategic investment, OrbitalRX is poised to accelerate its product development roadmap and expand its market footprint. The company is expected to leverage this capital to enhance its predictive analytics capabilities, allowing for more precise forecasting of drug shortages before they impact clinical operations. Furthermore, the infusion of resources will likely support aggressive customer acquisition strategies, targeting large-scale hospital networks and health systems that require sophisticated, real-time supply chain visibility. As the company transitions into this next phase of growth, the focus will remain on solidifying its position as an indispensable partner for pharmacy executives navigating an increasingly complex global pharmaceutical landscape.
See full OrbitalRX company page
